Clinical trial Recruiting at 2 sites Interventional Women only

Teaching parents to test breastmilk sodium levels in preterm infants

Official title: Partnering With Parents for Pumping Success: Feasibility of Personalized Lactation Support Utilizing Point-of-Care Human Milk Biomarkers

Run by The Hospital for Sick Children · NCT06563726 · Data updated 2026-11-12

This study is testing if teaching parents how to check the sodium levels in their breastmilk can help improve milk production for their preterm babies.

More Preterm Birth trials

Quick facts

Study typeInterventional
SexWomen only
Enrollment40 (estimated)
SponsorThe Hospital for Sick Children
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Seattle, Washington and 1 other locations)
StatusRecruiting
StartedMarch 10, 2025
Main results expectedDecember 2025
Study endsMarch 2026
Registry record updatedMay 28, 2025
Trial IDNCT06563726 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are lactating parents of preterm infants born at less than 35 weeks gestation who plan to initiate lactation with a breast pump.

Probably not a fit

Patients whose infants are critically ill or have lethal diagnoses, or those with contraindications to lactation, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study focuses on educating lactating parents of hospitalized preterm infants on how to measure the sodium content in their breastmilk using point-of-care meters. The study aims to establish the feasibility and acceptance of parent-led sodium testing within the first two weeks postpartum. It will also explore the relationship between pumping behaviors, lactation risk factors, and sodium levels in breastmilk to improve lactation outcomes. The goal is to empower parents with knowledge that may enhance milk production for their vulnerable infants.

Why it matters

Potential benefit: If successful, this approach could lead to improved lactation outcomes and milk volumes for parents of preterm infants.

How similar studies have gone: While this approach is innovative, similar studies have not been widely reported, making this a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Consent provided
2. Have delivered a preterm singleton or twin infant at \<35 weeks gestation admitted to a study NICU at birth or transferred into a study NICU from another NICU within the first 72 hours postpartum
3. Day 5 or less postpartum (Day 1 = day of delivery) upon enrollment (ideally day 3 or less)
4. Plans to lactate at least 2 weeks and initiate lactation with a breast pump
5. Expected infant NICU stay of 7+ (ideally 14+) days in enrollment NICU(s)

Exclusion Criteria:

1. Potential study participant's infant is critically ill and not expected to survive or has lethal diagnosis with plans by medical team/family to redirect care
2. Has delivered triplets or higher order multiples (potential confounder for lactation challenges; of note, triplets or higher are rare, on the order of a few parents annually)
3. Lactation contraindication(s) (i.e., active chemotherapy) or declines lactation initiation
4. History of breast surgery that may affect ability to lactate (i.e., breast reduction; breast augmentation that utilized nipple incisions)
5. Using or planning to use hormonal birth control in the first 14 days post-partum as may affect secretory activation/lactation
6. Unable/unwilling to be present in study NICU during any of first 5 days postpartum
7. Presumption by the medical team that infant will be in study NICU for \<5 days

Where it's running

  • Seattle Children's Hospital
    Seattle, Washington, United States
    Recruiting
  • University of Washington Medical Center - Montlake
    Seattle, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.